Ceragenix Pharmaceuticals' Chief Scientific Officer Awarded $1.2 Million Research Grant by National Institutes of Health.
Business Wire › August 17, 2005
Linked as:
Extract
Ceragenix Pharmaceuticals' Chief Scientific Officer Awarded $1.2 Million Research Grant by National Institutes of Health.
DENVER -- NIH Funded Study to Evaluate Ceragenix's Barrier Repair Technology as Potential Method to Prevent Potentially Fatal Complication of Smallpox Vaccinations in Persons Who Have Had Eczema
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company")(OTCBB:C...See the full content of this document
Sponsored links
